Drug Interaction Study Between AZD3355 and Nexium

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate if AZD3355 and Nexium interact with each other or not, i.e. show the same or altered plasma concentration profiles when co-administered compared to administered alone.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: AstraZeneca
• Treatments: Esomeprazole; Lesogaberan

Criteria

Inclusion Criteria:

• Provision of written informed consent

• Females no childbearing potential

• Clinically normal physical findings

Exclusion Criteria:

• Clinically significant illness within 2 weeks prior to the first dose of investigational product

• History of clinically significant disease

• Use of prescribed medication during the 2 weeks before administration of the first dose of investigational product